View : 307 Download: 0

Efficacy and Safety of Maca (<i>Lepidium meyenii</i>) in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Title
Efficacy and Safety of Maca (<i>Lepidium meyenii</i>) in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Authors
Shin, DonghoJeon, Seung HwanPiao, JunjiePark, Hyo JungTian, Wen JieMoon, Du GeonAhn, Sun TaeJeon, Kyung-HwaZhu, Guan QunPark, IlbumPark, Hyun-JeBae, Woong JinCho, Hyuk JinHong, Sung-HooKim, Sae Woong
Ewha Authors
전경화
SCOPUS Author ID
전경화scopus
Issue Date
2023
Journal Title
WORLD JOURNAL OF MENS HEALTH
ISSN
2287-4208JCR Link

2287-4690JCR Link
Citation
WORLD JOURNAL OF MENS HEALTH vol. 41, no. 3, pp. 692 - 700
Keywords
Herbal medicineHypogonadismLepidiumPhysiologicalSexual dysfunction
Publisher
KOREAN SOC SEXUAL MEDICINE &

ANDROLOGY
Indexed
SCIE; SCOPUS; KCI WOS scopus
Document Type
Article
Abstract
Purpose: To evaluated the efficacy and safety of gelatinized Maca (Lepidium meyenii) for eugonadal patients with late onset hypogonadism symptoms (LOH). Materials and Methods: Participants were instructed to receive 1,000 mg of Maca or placebo, two pills at a time, three times per day for 12 weeks before food intake. To evaluate the efficacy of the drug, Aging Males' Symptoms scale (AMS), Androgen Deficiency in the Aging Males (ADAM), International Prostate Symptom Score (IPSS), and International Index of Erectile Function (IIEF) questionnaires, serologic tests (total testosterone and free testosterone, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride), body weight, and waist circumference were assessed at 4 and 12 weeks after treatment. Results: A total of 80 participants were enrolled and randomly assigned to Maca treated group (n=41) or the placebo group (n=39). AMS, IIEF, and IPSS were significantly (p<0.05) improved in Maca treated group than in the placebo group. ADAM positive rate was also significantly (p<0.0001) decreased in Maca treated group. Conclusions: Maca may be considered an effective and safe treatment for eugonadal patients with late onset hypogonadism symptoms.
DOI
10.5534/wjmh.220112
Appears in Collections:
연구기관 > 약학연구소 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE